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Introduction
The symposium entitled “The role of the tubulointersti-
tium in hypertension and in the progression of renal dis-
ease” was organized as the opening event of the XX Con-
gress of the Chilean Society of Nephrology in Puco´n, Chile,
October 2, 2002. The aim of the symposium was to high-
light some selected aspects of otherwise seemingly bound-
less subjects. The symposium was attended by more than
200 participants in a particularly impressive surrounding
of lakes and volcanoes that characterize the marvelous
landscape of southern Chile. We believe it was a memo-
rable meeting and feel privileged to act as Guest Editors
of this supplement.
The articles collected here either review pathways that
are important in the development of chronic renal dam-
age and the pathogenesis of hypertension, or else present
novel experimental findings that may contribute to the
understanding of the pathophysiology of renal disease
and the role of the kidney in salt-sensitive hypertension.
This material does not pretend to give a balanced or
comprehensive view of these subjects; rather, it aims to
offer insights into areas that may turn out to be important
in the future. As such was the meeting designed, and as
such is this supplement presented.
We think that there is an additional aspect that de-
serves mention. The collaborative research activity be-
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tween Latin American laboratories and research labora-
tories in Europe and the United States is evident from
the themes and authorship lists included in the sympo-
sium. These collaborative programs indicate that Nephrol-
ogy—and research in Nephrology—is indeed global and
nowhere is this fact more evident than in Latin America.
The Puco´n symposium was made possible through the
joint sponsorship of the Commission for the Global Ad-
vancement of Nephrology (COMGAN) of the Interna-
tional Society of Nephrology, The Latin American Soci-
ety of Nephrology and Hypertension (SLANH), and the
Chilean Society of Nephrology. We thank them all for
their generous support.
Finally, the Guest Editors want to recognize the unwa-
vering help and encouragement we received from John
Dirks, COMGAN Chairman.
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